Evidence map›Paper›PMID 42267735›Full record

ArticleThe Kaohsiung journal of medical sciences2026

Knowledge Gaps, Treatment Preferences, and Unmet Clinical Needs Among Patients With Inflammatory Bowel Disease: A Cross-Sectional Study.

Yi-Chen Wu, Chien-Ming Chen, Tony Kou, Tai-Di Chen, Ming-Jung Meng, Chen-Wang Chang, Jen-Wei Chou, Tien-Yu Huang, Cheng-Tang Chiu, Yu-Bin Pan and 2 more

Abstract read
In one paragraph

Article in The Kaohsiung journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yi-Chen WuCollege of Medicine, Chang Gung University, Taoyuan City, Taiwan.
Chien-Ming ChenCollege of Medicine, Chang Gung University, Taoyuan City, Taiwan.ORCID https://orcid.org/0000-0001-7829-1504
Tony KouChang Gung Inflammatory Bowel Disease Center, Taoyuan, Taiwan.
Tai-Di ChenChang Gung Inflammatory Bowel Disease Center, Taoyuan, Taiwan.ORCID https://orcid.org/0000-0002-4231-7677
Ming-Jung MengChang Gung Inflammatory Bowel Disease Center, Taoyuan, Taiwan.
Chen-Wang ChangTaiwan Association for the Study of Intestinal Diseases (TASID), Taoyuan, Taiwan.ORCID https://orcid.org/0000-0002-3744-4129
Jen-Wei ChouTaiwan Association for the Study of Intestinal Diseases (TASID), Taoyuan, Taiwan.
Tien-Yu HuangTaiwan Association for the Study of Intestinal Diseases (TASID), Taoyuan, Taiwan.
Cheng-Tang ChiuCollege of Medicine, Chang Gung University, Taoyuan City, Taiwan.
Yu-Bin PanBiostatistical Section, Clinical Trial Center, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
Puo-Hsien LeCollege of Medicine, Chang Gung University, Taoyuan City, Taiwan.ORCID https://orcid.org/0000-0002-1100-5371
Ming-Yao SuCollege of Medicine, Chang Gung University, Taoyuan City, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study utilized a cross-sectional survey via a structured questionnaire to evaluate disease-related knowledge, treatment preferences, and unmet needs among 200 adults with confirmed inflammatory bowel disease (IBD) at a tertiary referral center. The questionnaire specifically assessed disease knowledge using the 24-item IBD-KNOW score, priorities for treatment attributes, preferred administration modalities, and self-reported unmet needs. Results indicated a mean IBD-KNOW score of 14.8/24, reflecting moderate overall knowledge, with female sex identified as an independent predictor of higher knowledge levels (OR: 1.87, p = 0.044). In terms of treatment, patients prioritized efficacy (8.9/10) over safety (8.5) and convenience (8.1); notably, 49% ranked efficacy as the most important factor, whereas 88% ranked convenience as the least important. The most preferred administration modalities were once-daily oral therapy (31%) and bimonthly subcutaneous injection (29.5%). While 43.5% of respondents reported no unmet needs, significant concerns persisted regarding the fear of disease progression (24.5%), medication cost (22.5%), and long waiting times for care (20.5%). These findings suggest that although IBD patients possess moderate disease-specific knowledge and place a strong emphasis on treatment efficacy and long-interval regimens, clinical focus is still needed to address ongoing anxieties regarding long-term outcomes, financial burdens, and healthcare access.

Indexed as

advanced therapyIBD‐KNOWsteroidstreatment preferencesunmet needs

Identifiers

PMID42267735
PMCPMC13399891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.